Skip to main content

Gains in tuberculosis control threatened by drug resistance (downtoearth,)

Gains made in controlling tuberculosis (TB) are now threatened by growing drug-resistance in the bacteria that causes it. Experts from various countries including India, China and South Africa expressed their concern in an article published in the journal Lancet Respiratory Medicine, on March 23.

They opine that the rise and spread of two kinds of drug resistant TB—multi-drug resistant (MDR) and extremely drug resistant (XDR) tuberculosis—mirrors the spread of antimicrobial resistance against malaria, HIV and gram negative pathogens. It is believed that drug resistant-TB resulted out of poor compliance of treatment regimens and programmatic failure is now being questioned.

The multi-drug resistant variant of TB remains unaffected by two of the most powerful anti-TB drugs, isoniazid and rifampicin. XDR-TB, is a form of drug-resistant TB with additional resistance to more anti-TB drugs that therefore responds to even fewer available medicines. XDR-TB involves resistance to isoniazid and rifampicin, another family of drugs called fluoroquinolones, and at least one of the three injectable second-line drugs.

The authors say that sub-optimal drug delivery may be one of the reasons for increase in drug resistant TB. To overturn this, the authors stress on new and repurposed drugs (such as bedaquiline) and updated policies.

Another article published in the same journal says that the TB-causing pathogen Mycobacterium tuberculosis had a 50-year head start in developing resistance to the current first line of treatment. It also points to the lack of commitment to address drug-resistant TB, which can now be a transmitted from one person to another. The authors propose that over the next decade, drug-resistant TB can spread in an unprecedented scale. Thus, its addressal will require a stronger commitment from high-burden countries, the article adds.

India is a hub for TB and its drug-resistant variants, according to the World Health Organization (WHO). The Global Tuberculosis Report 2016 reveals that India has been underreporting TB incidence by a large margin. The Union health ministry aims to eradicate the disease by 2025, but that cannot be done without addressing drug-resistance.

Comments

Popular posts from this blog

NGT terminates chairmen of pollution control boards in 10 states (downtoearth,)

Cracking the whip on 10 State Pollution Control Boards (SPCBs) for ad-hoc appointments, the National Green Tribunal has ordered the termination of Chairpersons of these regulatory authorities. The concerned states are Himachal Pradesh, Sikkim, Tamil Nadu, Uttarakhand, Kerala, Rajasthan, Telangana, Haryana, Maharashtra and Manipur. The order was given last week by the principal bench of the NGT, chaired by Justice Swatanter Kumar. The recent order of June 8, 2017, comes as a follow-up to an NGT judgment given in August 2016. In that judgment, the NGT had issued directions on appointments of Chairmen and Member Secretaries of the SPCBs, emphasising on crucial roles they have in pollution control and abatement. It then specified required qualifications as well as tenure of the authorities. States were required to act on the orders within three months and frame Rules for appointment [See Box: Highlights of the NGT judgment of 2016 on criteria for SPCB chairperson appointment]. Having

High dose of Vitamin C and B3 can kill colon cancer cells: study (downtoearth)

In a first, a team of researchers has found that high doses of Vitamin C and niacin or Vitamin B3 can kill cancer stem cells. A study published in Cell Biology International showed the opposing effects of low and high dose of vitamin C and vitamin B3 on colon cancer stem cells. Led by Bipasha Bose and Sudheer Shenoy, the team found that while low doses (5-25 micromolar) of Vitamin C and B3 proliferate colon cancer stem cells, high doses (100 to 1,000 micromolar) killed cancer stem cells. Such high doses of vitamins can only be achieved through intravenous injections in colon cancer patients. The third leading cause of cancer deaths worldwide, colon cancer can be prevented by an intake of dietary fibre and lifestyle changes. While the next step of the researchers is to delineate the mechanisms involved in such opposing effects, they also hope to establish a therapeutic dose of Vitamin C and B3 for colon cancer stem cell therapy. “If the therapeutic dose gets validated under in vivo

SC asks Centre to strike a balance on Rohingya issue (.hindu)

Supreme Court orally indicates that the government should not deport Rohingya “now” as the Centre prevails over it to not record any such views in its formal order, citing “international ramifications”. The Supreme Court on Friday came close to ordering the government not to deport the Rohingya. It finally settled on merely observing that a balance should be struck between humanitarian concern for the community and the country's national security and economic interests. The court was hearing a bunch of petitions, one filed by persons within the Rohingya community, against a proposed move to deport over 40,000 Rohingya refugees. A three-judge Bench, led by Chief Justice of India Dipak Misra, began by orally indicating that the government should not deport Rohingya “now”, but the government prevailed on the court to not pass any formal order, citing “international ramifications”. With this, the status quo continues even though the court gave the community liberty to approach i